Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
Eagle Materials (EXP) is trading near its 52-week low despite record revenue, solid free cash flow and strong returns on equity. With infrastructure spending and nonresidential demand supporting cement and aggregates, the setup looks like a classic oversold cyclical recovery. This trade idea lays out a clear entry, stop and target for a long-term d…
Carpenter Technology Corporation has announced a succession in the role of General Counsel, marking an internal leadership change within the company's legal department.
Sundial Growers Inc. has announced that it will release its financial results for the third quarter of 2026 on October 27, 2026. No further details about expected results or guidance were provided.
Aktis Oncology is a pre-revenue radiopharmaceutical company with two clinical-stage miniprotein radioconjugates. With a $916.6M market cap, roughly $538.5M in cash backing, and early clinical imaging/dosimetry data plus upcoming clinical milestones, the risk-reward favors a long-biased swing-to-position trade. We lay out an entry at $16.50, a stop …
Toast is showing strong revenue growth and accelerating earnings as operating leverage kicks in. At roughly $17.3B market cap and a current price near $30, the stock offers asymmetric upside if management continues to convert revenue growth into free cash flow. This trade targets $38 over a mid-term 45 trading day horizon with a disciplined stop at…
Phillips 66 (PSX) combines strong refining economics, growing midstream scale, and a disciplined capital return profile. At roughly $118.6B market cap, a 16x P/E and $6.4B of free cash flow support a dividend yield near 1.7% and room for continued buybacks. This trade idea targets $330 with an entry at $295 and a stop at $274 for a mid-term hold (4…
UnitedHealth reported a strong Q3 with adjusted EPS of $4.69 and raised 2026 guidance to at least $20.50. Improved medical cost management and accelerating Optum Insight/Rx results mean the company is earning more from less. The trade: enter at $395.75, stop at $375.00, target $435.00 over a mid-term (45 trading days) horizon.
GSK's mix of strong specialty-medicine growth, a growing long‑acting HIV franchise, and selective oncology licensing deals creates a compelling risk-reward. At a $97B market cap, mid‑teens P/E and a 3.9% yield, GSK offers both capital appreciation and income. This trade plan targets a 19% upside to $57 with a protective stop at $44 over a 180‑day h…
RTX enters 3Q with two visible growth levers - Pratt & Whitney commercial and military engine cycles plus expanding demand for missile, counter-drone and cyber systems - supported by strong free cash flow and a conservative balance sheet. We view the stock as a buy into the October 20, 2026 print with a tactical mid-term trade plan and defined risk…
Sterling Infrastructure (STRL) has reset the growth-vs-margin tradeoff: management is steering Transportation toward higher-margin work, margins are already expanding, and the company generates healthy free cash flow with low leverage. With a market cap near $13.7B, a history of earnings beats and a positive earnings ESP, the upcoming earnings rele…
Sterling Infrastructure (STRL) looks buyable after recent weakness. The company pairs a low leverage profile and $482M of free cash flow with high-return operations (ROE ~32%) and a clear strategic tilt toward higher-margin data-center and e-infrastructure projects. Valuation is rich at a P/E ~36 and EV/EBITDA ~21.5, but the risk/reward favors a di…
Nu Holdings has transitioned from growth-at-all-costs to profitable fintech with durable unit economics. Q2 2026 showed >$1B quarterly net income, ARPAC at $17, and accelerating revenue. At a market cap near $73.3B and a P/E around 21, the stock offers a favorable risk-reward even if Brazilian politics remain uncertain. Trade plan provided with ent…
Aegon is executing a multi-year simplification and capital-return plan that should materially reduce holding-company drag and lift per-share metrics. At $8.25 the stock trades at ~11x earnings and a ~4.95% yield while technicals show an oversold base. This trade idea targets the 52-week high near $9.60 on a 180-trading-day horizon while preserving …
Cellnex Telecom (CLNX) offers exposure to Europe’s fastest-growing tower market at a valuation materially below U.S. tower peers. This trade idea recommends a long position with a $35.50 entry, $48.00 target and $29.00 stop, targeting upside from macro and company-specific catalysts over a 180 trading day horizon.
Nvidia shares pulled back from a recent 52-week high, offering an actionable long with defined risk. Strong free cash flow ($127B trailing), dominant data-center positioning and healthy profitability (ROE ~84%) support a mid-to-long-term push higher. This trade targets a move back above $260 over the next 180 trading days with a tight stop to limit…
UBS told clients that its stance of buying the U.S. dollar on dips remains appropriate provided energy prices stay high and the AI-driven investment narrative endures. The bank highlighted persistent European vulnerabilities tied to gas inventories and said the euro remains vulnerable on rallies, while commodity currencies are in a consolidation ph…
The Hershey Company (HSY) has pulled back into a technically attractive area after a summer peak; fundamentals still support a tactical long while near-term demand and margin pressure tied to changing consumer behavior are real. We upgrade to a buy for a swing trade: entry at $162.00, stop at $155.00, target $175.00 over ~45 trading days, with clea…
Indivior's SUBLOCADE continues to drive top-line growth while management's cost discipline has materially improved profitability. At roughly $35.90 today and trading around low-double-digit P/E, the stock offers a risk-reward favorable to the long side. This trade idea lays out an entry, stop, targets and the thesis drivers to own INDV over the nex…
Aris Mining trades at roughly $3.36B market cap with a PE of 12.2 and PB near 2.0 while technicals show a near-term oversold setup. With management guiding a material lift in output and gold prices still elevated, Aris looks attractively priced for a long trade targeting re-rating as production doubles and cash flow ramps.
Southern Company (SO) is a core utility with durable earnings, an attractive dividend and clear growth avenues through Southern Power and gas distribution. Near-term cash-flow pressure and a customer-data breach create headline risk. We like SO as a long-term trade for capital appreciation back toward its former highs and steady income, but recomme…
Atlantic Union (AUB) trades at roughly $37.40 with a market cap near $5.34B, a P/E of ~11.2, and P/B around 1.03. The shares look oversold technically (RSI ~33) and the headline risk from 2024 M&A has largely been absorbed; a positive earnings backdrop and a 3.9% dividend make a mid-term long trade attractive ahead of catalysts.
Broadcom benefits from surging demand for custom AI accelerators and infrastructure software, and recent financing deals lock in large order streams. The stock trades below near-term moving averages and offers a trade opportunity: buy into weakness with a clear stop while watching execution and margin signals over the next 180 trading days.
Micron (MU) is down sharply on recent headlines about China competition and AI fears. Fundamentals - including $59B in free cash flow, a massive $35.16B buyback, DRAM tightness for AI, and a sub-13x P/E - argue the pullback is an overreaction. This trade idea lays out an entry, stop, targets and why the risk/reward favors a buy over the next 45 tra…
Hims & Hers (HIMS) is a growthy telehealth play that has momentum, but a heavy legal/regulatory overhang, thin free cash flow relative to market cap, and a business model tied to third-party advertising make it a weaker beneficiary of healthcare AI than scale-driven pharmacy services. I recommend a tactical short: entry $28.76, target $16.00, stop …
Cirrus Logic moved to M&A to accelerate development in higher-performance mixed-signal and AI-ready audio camera domains. Strong FCF, no net debt and a sub-13x earnings multiple make a tactical long attractive around $107 with a clear stop and target. This trade banks on successful integration and renewed design wins from Apple's device roadmap as …
